Bicycle Therapeutics (BCYC)
(Delayed Data from NSDQ)
$23.97 USD
-1.44 (-5.67%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $23.91 -0.06 (-0.25%) 4:28 PM ET
2-Buy of 5 2
F Value D Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/07/2024
Time: -- |
9/2024 | $-0.78 | 0.00% |
Earnings Summary
For their last quarter, Bicycle Therapeutics (BCYC) reported earnings of -$0.77 per share, beating the Zacks Consensus Estimate of $-1.10 per share. This reflects a positive earnings surprise of 30.00%. Look out for BCYC's next earnings release expected on November 07, 2024. For the next earning release, we expect the company to report earnings of -$0.78 per share, reflecting a year-over-year increase of 38.1%.
Earnings History
Price & Consensus
Zacks News for BCYC
Wall Street Analysts See an 88.94% Upside in Bicycle Therapeutics (BCYC): Can the Stock Really Move This High?
BCYC: What are Zacks experts saying now?
Zacks Private Portfolio Services